Drugs / MV mix vaccine
last change Aug 2015 re-read 3 minutes ago

MV mix vaccine

Developed for
lung neoplasm
Investigated by
Fuda Cancer Hospital, Guangzhou

Trials 1

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02333474 Jan → Aug 2015 lung neoplasm Fuda Cancer Hospital, Guangzhou Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MV mix vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02333474 ↗
Route Subcutaneous “Inject 0.5 ml of the mixture subcutaneously every week.” NCT02333474 ↗